FOXD2-AS1 promotes breast cancer cell proliferation, invasion, migration, and drug resistance by positively regulating the PI3K/AKT signaling pathway, inhibits apoptosis, and accelerates breast cancer progression (Nong et al., 2021). The gene discussed is AKT1; the disease is breast carcinoma.